Medscape September 30, 2025
From mood trackers to guided cognitive-behavioral therapy (CBT) and peer support, depression apps are crowding the digital marketplace. As more patients turn to this technology to ease their symptoms, physicians are faced with figuring out their potential role in clinical practice.
Unlike other psychiatric disorders, which have few digital therapeutic options, there are myriad apps aimed at depression, although only a handful are evidence-based or FDA-cleared.
Many are marketed as “wellness” interventions, bypassing regulatory oversight, leaving clinicians to navigate which have the potential to augment traditional treatment safely and effectively, how to discuss them with patients, and the ethical considerations involved.
“You don’t have to use these apps yourself, but you need to be at least aware of what your...
Today's Sponsors
Today's Sponsor